Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 1048 entries
View as:

VIC Regimen Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05540951 Org: User:
Start: 06/01/18 End: 12/30/22 Due: 12/30/23

Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04508829 Org: User:
Start: 01/01/16 End: 12/01/23 Due: 12/01/24

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06475326 Org: User:
Start: 06/05/24 End: 12/31/25 Due: 12/31/26

Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01322178 Org: User:
Start: 12/31/10 End: 12/31/13 Due: 12/31/14

Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02916511 Org: User:
Start: 09/01/16 End: 07/01/23 Due: 07/01/24

HER2-positive Breast Cancer Project Initiated by Investigators

Phase: N/A Priority: Normal
NCT ID: NCT05346328 Org: User:
Start: 06/01/22 End: 12/31/24 Due: 12/31/25

Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT06996093 Org: User:
Start: 06/02/25 End: 06/01/34 Due: 06/01/35

SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06210438 Org: User:
Start: 02/01/24 End: 06/30/26 Due: 06/30/27

A Phase II Trail of Chidamide ,Rituximab and Methotrexate in Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT04516655 Org: User:
Start: 09/01/20 End: 08/30/23 Due: 08/30/24

PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC

Phase: N/A Priority: Normal
NCT ID: NCT06156891 Org: User:
Start: 06/29/22 End: 07/30/25 Due: 07/30/26

Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00460681 Org: User:
Start: 02/28/07 End: 02/29/12 Due: 02/28/13

Clinical Phenotype and Omics Study of KCNQ2-related Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT05157737 Org: User:
Start: 01/01/21 End: 12/31/24 Due: 12/31/25

C-Reactive Protein (CRP) Gene Variants and Coronary Artery Disease in a Chinese Han Population

Phase: N/A Priority: Normal
NCT ID: NCT00780221 Org: User:
Start: 10/31/08 End: 12/31/10 Due: 12/31/11

A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02137083 Org: User:
Start: 04/30/14 End: 07/31/17 Due: 07/31/18

A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01149798 Org: User:
Start: 06/30/10 End: 11/30/11 Due: 11/30/12

Acute Health Effects of Low Temperature Exposure

Phase: N/A Priority: Normal
NCT ID: NCT06076629 Org: User:
Start: 10/10/23 End: 12/31/24 Due: 12/31/25

CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06182735 Org: User:
Start: 07/17/23 End: 01/28/25 Due: 01/28/26

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03889626 Org: User:
Start: 03/22/19 End: 03/22/24 Due: 03/22/25

Study of Apatinib in Metastatic Triple-Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01176669 Org: User:
Start: 06/30/10 End: 09/30/14 Due: 09/30/15

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT04912258 Org: User:
Start: 08/01/21 End: 06/01/23 Due: 06/01/24

Clinical Trial on the Effectiveness of Traditional Chinese Medicinal Mixture in Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT00629161 Org: User:
Start: 11/30/08 End: - Due: -

Study Comparing EC-T Verses PCb in the Adjuvant Chemotherapy of Non-triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04193059 Org: User:
Start: 08/01/18 End: 07/31/24 Due: 07/31/25

Preservation Vs. Dissection of No. 253 Lymph Nodes of Robotic Resection for Mid/Low Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06956976 Org: User:
Start: 06/01/25 End: 06/01/31 Due: 06/01/32

Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

Phase: N/A Priority: Normal
NCT ID: NCT00554125 Org: User:
Start: 08/31/07 End: 08/31/13 Due: 08/31/14

A Cohort of Molecular Characteristics and Prognosis of Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05086601 Org: User:
Start: 12/01/20 End: 09/09/22 Due: 09/09/23